(Q30233313)

11 June 2017

1 reference

title

The threat and prospects for control of an influenza pandemic (English)

1 reference

11 June 2017

0 references

1 reference

H Grant Stiver

1

1 reference

11 June 2017

publication date

1 February 2004

1 reference

Expert Review of Vaccines

11 June 2017

published in

1 reference

11 June 2017

volume

3

1 reference

11 June 2017

issue

1

1 reference

11 June 2017

page(s)

35-42

1 reference

Outbreaks of influenza A in nursing homes in Sheffield during the 1997-1998 season: implications for diagnosis and control.

11 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Global epidemiology of influenza: past and present.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Current research on respiratory viral infections: Third International Symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

The pathogenesis of influenza in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

Early administration of oral oseltamivir increases the benefits of influenza treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.35

21 January 2018

Identifiers

DOI

10.1586/14760584.3.1.35

1 reference

11 June 2017

1 reference